Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 5, 2025Russian Journal of Preventive Medicine

A review of the recent clinical studies on the treatment of patients with the chronic kidney disease et advanced stages

View Full Paper
Ask AI
Bookmark
Share

Authors

AAA.S. AnanevaARA. P. RomashovaABA.E. Bryndina

Discussion

Loading...

Member takes

Overview

This review analyzes nephroprotective drugs in treating chronic kidney disease, highlighting key strategies and outcomes.

Key Points

  • Nephroprotective agents slow chronic kidney disease progression and improve outcomes.
  • Renin-angiotensin system inhibitors significantly reduce end-stage renal disease risk.
  • The combination of specific drug classes enhances nephroprotection in patients with type 2 diabetes.
  • Modern treatments for anemia are as effective as traditional agents, enhancing patient care.

Cite This Study

Ananeva et al. (2025) studied this question.

synapsesocial.com/papers/68c2384fb210217d64777374https://doi.org/10.17116/profmed202528081110
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic approaches in the management of chronic kidney disease: the past, the present, and the future2025
  2. 2Optimizing care for chronic kidney disease: Considerations from A to Z.2025 · 3 citations
  3. 3Novel Management Approaches Diabetic Kidney Disease and Chronic Kidney Disease: A Systematic Review2025
  4. 4Endothelial Dysfunction and Therapeutic Advances in Chronic Kidney Disease2025 · 9 citations
  5. 5Hypertension in Advanced Chronic Kidney Disease: Saving the Kidneys or the Heart?2026